TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17498484

Group type: EXPERIMENTAL
Intervention: Yiqi Sanju Formula (YQSJF)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 15136785

Group type: EXPERIMENTAL
Intervention: SRD5A1 polymorphisms
Number of subjects: 0

Group type: COMPARATOR
Intervention: SRD5A2 polymorphisms
Number of subjects: 0
Study: 11222787

Group type: EXPERIMENTAL
Intervention: Remacemide 150 mg/d
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Remacemide 300 mg/d
Number of subjects: 279

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study: 9932140

Group type: EXPERIMENTAL
Intervention: Supervised outpatient, hospital-based cardiac rehabilitation
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 3
Study: 7997845

Group type: EXPERIMENTAL
Intervention: Dietary advice combined with self monitoring of morning urine chloride concentration for 12 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Dietary advice alone
Number of subjects: 34
Study: 3412591

Group type: EXPERIMENTAL
Intervention: Amitriptyline (12.5 to 150 mg/d)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 58

Group type: COMPARATOR
Intervention: Lorazepam (0.5 to 6 mg/d)
Number of subjects: 58
Study: 30402720

Group type: EXPERIMENTAL
Intervention: Faster aspart
Number of subjects: 1215

Group type: COMPARATOR
Intervention: IAsp
Number of subjects: 1215
Study: 28922591

Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-20.0 mg/d)
Number of subjects: 161
Study: 25593016

Group type: EXPERIMENTAL
Intervention: Docetaxel (75mg/m² IV every 21 days) with PX-866 (8mg PO daily)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Docetaxel (75mg/m² IV every 21 days) without PX-866
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Docetaxel with PX-866
Number of subjects: 85

Group type: COMPARATOR
Intervention: Docetaxel without PX-866
Number of subjects: 85
Study: 23412986

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) 3 mg/kg/d for 3 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Propranolol 1 mg/kg for 3 months
Number of subjects: 100
Study: 22321321

Group type: EXPERIMENTAL
Intervention: 30 mg pioglitazone hydrochloride once daily for 16 weeks
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 20183452

Group type: EXPERIMENTAL
Intervention: Weighted-Least-Squares (WLS) test statistic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Logarithmic transformation of the WLS (LWLS) test statistic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Squared-root transformation of the LWLS (SLWLS) test statistic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fisher's logarithmic transformation of LWLS (LLWLS) test statistic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Z-transformation of LWLS (ZLWLS) test statistic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LWLS test statistic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ZLWLS test statistic
Number of subjects: 0
Study: 17124820

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 14745704

Group type: EXPERIMENTAL
Intervention: PIV3-cp45 vaccine
Number of subjects: 380

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 380
Study: 11728891

Group type: EXPERIMENTAL
Intervention: One-session intervention based on the information‐motivation‐behavioral skills (IMB) model
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: One-session information‐only intervention (INFO)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Wait-list control (WLC) group
Number of subjects: 78
Study: 9682687

Group type: EXPERIMENTAL
Intervention: Touch-sensitive computer system (TSCS) with registered nurse liaison
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Touch-sensitive computer system (TSCS) users
Number of subjects: 507
Study: 7977116

Group type: EXPERIMENTAL
Intervention: Exercise-induced silent ischemia (SI) in men
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Exercise-induced silent ischemia (SI) in women
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Prevalence of SI by age in men
Number of subjects: 281

Group type: COMPARATOR
Intervention: Comparison of men with SI to men with normal exercise ECG and thallium scan
Number of subjects: 281

Group type: COMPARATOR
Intervention: Comparison of men with SI to men with overt CAD
Number of subjects: 281
Study: 2920455

Group type: EXPERIMENTAL
Intervention: Canine fossa approach under local anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inferior meatus approach
Number of subjects: 0
Study: 31347178

Group type: EXPERIMENTAL
Intervention: Assertiveness training for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31527299

Group type: EXPERIMENTAL
Intervention: Conditioned Pain Modulation (CPM) effect measured 6 weeks after hospital discharge
Number of subjects: 111

Group type: COMPARATOR
Intervention: Non-randomized surgical treatment
Number of subjects: 111
Study: 28454992

Group type: EXPERIMENTAL
Intervention: VarioGuide (VG)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Frame-Based (FB)
Number of subjects: 53
Study: 25833969

Group type: EXPERIMENTAL
Intervention: High-egg diet (2 eggs/d for 6 d/wk)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Low-egg diet (<2 eggs/wk)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: High-egg diet
Number of subjects: 140

Group type: COMPARATOR
Intervention: Low-egg diet
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 140
Study: 23692328

Group type: EXPERIMENTAL
Intervention: Daily intake of 150-200 ml milk
Number of subjects: 0

Group type: COMPARATOR
Intervention: Twice weekly intake of 150-200 ml milk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both regimens (daily and twice weekly)
Number of subjects: 0
Study: 21502577

Group type: EXPERIMENTAL
Intervention: Atopaxar (400 mg loading dose followed by 50, 100, or 200 mg daily)
Number of subjects: 603

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Atopaxar (combined)
Number of subjects: 603
Study: 19254122

Group type: EXPERIMENTAL
Intervention: Bovine porous bone mineral (BPBM) alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Bovine porous bone mineral (BPBM) plus collagen membrane (CM)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 45
Study: 16627375

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle adjustments
Number of subjects: 3234

Group type: EXPERIMENTAL
Intervention: Metformin therapy
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3234
Study: 15228506

Group type: EXPERIMENTAL
Intervention: Sighted Guide (SG) technique
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Non-Sighted Guide (NSG) technique
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: String (ST) technique
Number of subjects: 40
Study: 14679280

Group type: EXPERIMENTAL
Intervention: Integrated Management of Childhood Illness (IMCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison districts (non-IMCI)
Number of subjects: 0
Study: 10880808

Group type: EXPERIMENTAL
Intervention: Multiple Point Stimulation (MPS) technique
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Collision technique
Number of subjects: 4
Study: 8715845

Group type: EXPERIMENTAL
Intervention: Axillary temperatures
Number of subjects: 173

Group type: COMPARATOR
Intervention: Rectal temperatures
Number of subjects: 173

Group type: COMPARATOR
Intervention: Oral temperatures
Number of subjects: 173
Study: 1398956

Group type: EXPERIMENTAL
Intervention: Single 5 x 10(8)‐CFU dose of live oral recombinant cholera vaccine CVD 103‐HgR
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 3987797

Group type: EXPERIMENTAL
Intervention: Trimebutine 100 mg i.v.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3358881

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg three times daily
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pindolol 5 mg three times daily
Number of subjects: 17

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 17

Group type: COMPARATOR
Intervention: Pindolol
Number of subjects: 17
Study: 31152023

Group type: EXPERIMENTAL
Intervention: Regimen-DI (doxorubicin 6×75 mg/m2/week; cisplatin 6×100 mg/m2/week every 2 weeks)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Regimen-C (doxorubicin 6×75 mg/m2/week; cisplatin 6×100 mg/m2/week every 3 weeks)
Number of subjects: 497
Study: 28417910

Group type: EXPERIMENTAL
Intervention: L-CHO
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: H-CHO
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CHO-PRO
Number of subjects: 10

Group type: COMPARATOR
Intervention: PLA (Placebo control)
Number of subjects: 10
Study: 26120745

Group type: EXPERIMENTAL
Intervention: Brief cognitive-behavioral educational session
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 85
Study: 23235355

Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Moxonidine 0.4 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 21692291

Group type: EXPERIMENTAL
Intervention: Proximal needling at Huantiao (GB 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine acupuncture at Huantiao (GB 30), Yinmen (BL 37), Weizhong (BL 40), Yanglingquan (GB 34)
Number of subjects: 60
Study: 19874586

Group type: EXPERIMENTAL
Intervention: Saliva biospecimens collected using Oragene(R) DNA Self‐Collection Kits
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Saliva volume
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Saliva clarity
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: DNA yield measured by UV
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: % human DNA content
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Correlation between saliva volume and DNA yield
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Genotyping completion rate
Number of subjects: 565
Study: 18044102

Group type: EXPERIMENTAL
Intervention: Racemic albuterol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Levalbuterol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 12
Study: 14749569

Group type: EXPERIMENTAL
Intervention: Topical autologous platelet‐enriched plasma combined with bovine collagen and thrombin (PCT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Gelfoam/thrombin (G/T)
Number of subjects: 78
Study: 11148527

Group type: EXPERIMENTAL
Intervention: pH‐dependent, enteric‐coated peppermint oil capsules
Number of subjects: 42

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study: 9631143

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: recombinant human insulin-like growth factor type 1 (rhIGF-1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: combination of rhGH and rhIGF-1
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All therapies (rhGH, rhIGF-1, combination)
Number of subjects: 24
Study: 7829435

Group type: COMPARATOR
Intervention: Dose schedule No.1 (group 2)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Dose schedule No.2 (group 3)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (group 1)
Number of subjects: 155
Study: 3276281

Group type: EXPERIMENTAL
Intervention: Isocarboxazid
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 30816056

Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rabeprazole 10 mg/day
Number of subjects: 40
Study: 28075321

Group type: EXPERIMENTAL
Intervention: lifestyle and exercise intervention for 12 months
Number of subjects: 136

Group type: COMPARATOR
Intervention: standard nephrological care
Number of subjects: 136
Study: 25381337

Group type: EXPERIMENTAL
Intervention: Lean mass-ratio standard
Number of subjects: 1170

Group type: EXPERIMENTAL
Intervention: Weight-ratio standard
Number of subjects: 1170
Study: 23406699

Group type: EXPERIMENTAL
Intervention: Peaked cap (CAP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No peaked cap (NOCAP)
Number of subjects: 19
Study: 20947174

Group type: EXPERIMENTAL
Intervention: Paliperidone ER (3-12 mg/day) as adjunctive therapy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Mood stabilizer monotherapy (valproate or lithium)
Number of subjects: 300
Study: 19277690

Group type: EXPERIMENTAL
Intervention: 400 microg misoprostol sublingually
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0.2 mg methyl‐ergometrine intramuscularly
Number of subjects: 200

Group type: COMPARATOR
Intervention: 125 microg 15-methyl PGF2alpha intramuscularly
Number of subjects: 200
Study: 16364165

Group type: EXPERIMENTAL
Intervention: Allergic nasal challenge (grass pollen)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo nasal challenge
Number of subjects: 9
Study: 15472840

Group type: EXPERIMENTAL
Intervention: Live, attenuated, cold-adapted influenza vaccine (CAIV-T)
Number of subjects: 0
Study: 11682400

Group type: EXPERIMENTAL
Intervention: tandospirone 10 mg (T10 group)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: tandospirone 30 mg (T30 group)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: diazepam 10 mg (D group)
Number of subjects: 160

Group type: COMPARATOR
Intervention: placebo (P group)
Number of subjects: 160
Study: 9135488

Group type: EXPERIMENTAL
Intervention: Ultrasound scanning (US)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Palpation
Number of subjects: 85
Study: 7896928

Group type: EXPERIMENTAL
Intervention: Rey Memory Test
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rey Memory Test with a cut-off score of 9 items remembered
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rey Memory Test with a cut-off of 3 rows remembered correctly
Number of subjects: 28
Study: 3680600

Group type: EXPERIMENTAL
Intervention: 25 mg nortriptyline test dose
Number of subjects: 18

Group type: COMPARATOR
Intervention: 50 mg nortriptyline
Number of subjects: 18

Group type: COMPARATOR
Intervention: 100 mg nortriptyline
Number of subjects: 18
Study: 30857604

Group type: EXPERIMENTAL
Intervention: Heavier sedation (modified OAA/S score 0-2)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Lighter sedation (modified OAA/S score 3-5)
Number of subjects: 200
Study: 28085707

Group type: EXPERIMENTAL
Intervention: Citicoline (100 mg twice a day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Citicoline
Number of subjects: 50
Study: 25401779

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) and lifestyle advice for 6 months
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (lifestyle advice only)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 109
Study: 24565240

Group type: EXPERIMENTAL
Intervention: Dexketoprofen with ilioinguinal-iliohypogastric nerve block (group DB)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Saline (group C)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Ilioinguinal-iliohypogastric nerve block (group B)
Number of subjects: 61
Study: 21371281

Group type: EXPERIMENTAL
Intervention: Preventive ceftriaxone treatment (2 g, given every 24 h intravenously for four days)
Number of subjects: 3200

Group type: COMPARATOR
Intervention: Standard care without preventive antibiotic treatment
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Preventive ceftriaxone treatment
Number of subjects: 3200
Study: 18422592

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol 1000 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline)
Number of subjects: 70
Study: 17202203

Group type: EXPERIMENTAL
Intervention: Sealed capsule irrigation (SCI) using distilled water for 2 minutes after phacoemulsification
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (fellow eye of each patient)
Number of subjects: 17
Study: 15189176

Group type: EXPERIMENTAL
Intervention: Subcutaneous epoetin alfa administration (group A)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Intravenous epoetin alfa administration (group B)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Intravenous epoetin alfa administration (group A after switch)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Subcutaneous epoetin alfa administration (group B after switch)
Number of subjects: 81
Study: 11173981

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study: 8988824

Group type: EXPERIMENTAL
Intervention: Mivacurium 0.15 mg.kg-1 followed by 0.1 mg.kg-1
Number of subjects: 32

Group type: COMPARATOR
Intervention: Rocuronium 0.9 mg.kg-1 followed by placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Divided dose mivacurium
Number of subjects: 32

Group type: COMPARATOR
Intervention: Rocuronium
Number of subjects: 32
Study: 8119084

Group type: EXPERIMENTAL
Intervention: Preoperative extracorporeal shock‐wave lithotripsy (ESWL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mechanical lithotripsy
Number of subjects: 10
Study: 3508426

Group type: EXPERIMENTAL
Intervention: DMSO (hydroxyl radical scavenger), administered locally 5 times a day for one week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo, administered for one week
Number of subjects: 0
Study: 31961756

Group type: EXPERIMENTAL
Intervention: Commercial tourniquet
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Improvised tourniquet
Number of subjects: 246
Study: 28922211

Group type: EXPERIMENTAL
Intervention: Ammonia inhalant (AI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No inhalants (N)
Number of subjects: 20
Study: 26879839

Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 24887747

Group type: COMPARATOR
Intervention: Topical clobetasol propionate 0.05% applied three times a day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Laser phototherapy (LPT) using InGaAlP diode laser applied three times a week
Number of subjects: 42
Study: 22383268

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive group therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 100
Study: 20646425

Group type: EXPERIMENTAL
Intervention: HCC > 10 cm group
Number of subjects: 316
Study: 18387775

Group type: EXPERIMENTAL
Intervention: Renal perfusion with venous blood
Number of subjects: 158

Group type: COMPARATOR
Intervention: Suprarenal clamping without renal perfusion
Number of subjects: 158
Study: 16423104

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 30
Study: 12592681

Group type: EXPERIMENTAL
Intervention: Hejie Decoction (HJD)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional western medicine (Control)
Number of subjects: 45
Study: 10599260

Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg once or twice a day)
Number of subjects: 1989

Group type: COMPARATOR
Intervention: Amoxicillin (3 g/d), Amoxicillin/clavulanic acid (1500 mg/d), Ceftriaxone (1-4 g/d)
Number of subjects: 1989

Group type: EXPERIMENTAL
Intervention: Levofloxacin (in patients with bacteriemia)
Number of subjects: 1989

Group type: COMPARATOR
Intervention: Comparators (in patients with bacteriemia)
Number of subjects: 1989
Study: 7499116

Group type: EXPERIMENTAL
Intervention: Endoxan
Number of subjects: 36

Group type: COMPARATOR
Intervention: Cytoxan
Number of subjects: 36

Group type: COMPARATOR
Intervention: Investigational direct compression tablet
Number of subjects: 36
Study: 1449568

Group type: EXPERIMENTAL
Intervention: Corticosteroids in combination with albuterol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group with different corticosteroids in combination with albuterol
Number of subjects: 15
Study: 4023255

Group type: EXPERIMENTAL
Intervention: Thallium 201 stress testing on treadmill (Tl-TM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Supine bicycle-ergometer-exercise thallium 201 testing (Tl-SB)
Number of subjects: 50
Study: 30630425

Group type: EXPERIMENTAL
Intervention: Lifting the epiglottis using stylets with a bend angle of 35°
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lifting the epiglottis using stylets with a bend angle of 50°
Number of subjects: 32

Group type: COMPARATOR
Intervention: Not lifting the epiglottis
Number of subjects: 32
Study: 30289802

Group type: COMPARATOR
Intervention: Asha-support only (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of nutrition supplementation and education
Number of subjects: 0
Study: 25182269

Group type: EXPERIMENTAL
Intervention: Stepped care model
Number of subjects: 860

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 860
Study: 21553949

Group type: EXPERIMENTAL
Intervention: Positive affect video induction
Number of subjects: 200

Group type: COMPARATOR
Intervention: Neutral video induction
Number of subjects: 200

Group type: COMPARATOR
Intervention: Neutral writing technique induction
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Positive affect writing technique induction
Number of subjects: 200
Study: 20660677

Group type: EXPERIMENTAL
Intervention: 5 mg/kg intravenous infusion of PRO 140
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 10 mg/kg intravenous infusion of PRO 140
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31